|
I.D. |
Technology |
Pat.
No.
(LINK TO
USPTO) |
|
ES-016 |
Tetracycline-Modulated Bicistronic Mammalian
Expression Vector |
|
|
ES-059 |
Plasmids DNA's for human and mouse TTP and
mammalian expression vectors for same |
|
|
HL-006 |
Use of Chimeric Murine Leukemia Virus LTRs in
Expressing Retroviral Vectors |
|
|
HL-016 |
Genetic Reassortment of Rotaviruses for
Production of Vaccine and Vaccine Precursor |
4,571,385 |
|
HL-062 |
Retroviral Vectors Containing Internal
Ribosome Entry |
|
|
HL-069 |
Adenovirus Mediated Transfer Of Genes To The
Gastrointestinal Tract |
|
|
HL-072 |
Inhibition of Cell Proliferation Using
Antisense Oligonucleotides |
|
|
HL-090 |
Improved Expression Of Human Multidrug
Resistance Genes And Improved Selection |
|
|
HL-116 |
Adenovirus Mediated Augmentation of Cell
Transfection With Unmodified Plasmid Vectors |
|
|
HL-121 |
Vector Systems For The Generation of Adeno-
Associated Virus Particles |
|
|
HL-122 |
Fusion Proteins Containing Adeno-Associated
Virus Rep Proteins |
|
|
HL-133 |
Novel Retroviral Envelope and LTR and
Retroviral Vector Particles |
|
|
HL-135 |
Gene Therapy to Promote Myocardial Blood
Vessel Growth |
|
|
HL-136 |
Adeno-Associated Virus Capable of Expressing
at Least One Globin Gene and Method |
|
|
HL-137 |
Lipid Vesicles Containing Adeno-Associated
Virus Rep Protein For Transgene Integration |
|
|
HL-146 |
Vector Particles Resistant to Inactivation by
Human Serum |
|
|
HL-149 |
Gene Therapy with Hirudin for Arterial
Proliferating Disease |
|
|
HL-153 |
Vectors Including Foreign Genes and Negative
Selective Markers |
|
|
HL-155 |
Organ Selective In Vivo Gene
Transfer |
|
|
HL-156 |
Promotion and Angiogenesis using
Adenoviral-modified endothelial cells and graft |
|
|
HL-161 |
Molecular Cloning of AAV and Use as a
Transduction Vector |
|
|
HL-169 |
High level production in vitro of human
coagulation factor IX from a recombinant Adeno-associated
virus. |
|
|
HL-170 |
Genetically Engineered Endothelial Cells and
uses Thereof |
|
|
HL-174 |
"Method for Development of Localized
Cell-mediated Immune Responses by Gene Transfer into Peripheral Blood
Monocyte/macrophages for the Treatment of Aids and Other Infections
Pathogens" |
|
|
HL-176 |
Delivery of Therapeutic Agents by Gene
Therapy |
|
|
HL-187 |
Method for Enhancement of Cell-mediated Immune
Responses by Gene Transfer into peripheral blood cells |
|
|
HL-188 |
Molecular Cloning of AAV5 and It's use as a
Transduction Vector |
|
|
HL-225 |
In vivo transduction of ependymal cells with
AAV4 vectors |
|
|
HL-226 |
In vivo of mouse lung with AAV5 vectors
|
|
|
HL-230 |
A chimeric Lentiviral vector with enhanced
gene expression. |
|
|
HL-237 |
Vectors encoding for the interaction domains
of proteins can interfere with those protein interactions |
|
|
HL-240 |
Methods for producing recombinant AAVs in
invertebrate cell lines |
|
|
HL-243 |
Adeno-associated virus (AAV) vector encoding
human coagulation factor VIII under transcription control |
|
|
HL-257 |
Methods for producing recombinant AAVs in
invertebrate cell lines |
|
| |
All
inquires should be directed to (301)-402-5579 |
|
